Table 2.
Effect of BCA on body weight, liver weight, and liver index of the rats with TAA-induced liver injury.
| Treatment | Initial Body Weight (g) | Final Body Weight (g) | Liver Weight (g) |
Liver Index (LW/BW %) |
|---|---|---|---|---|
| Normal control | 255 ± 31.22 | 473 ± 4.85 | 13 ± 3.14 | 3 ± 0.25 |
| TAA control | 260 ± 26.61 | 313 ± 36.12 * | 16 ± 2.23 * | 5 ± 0.12 * |
| Silymarin (50 mg/kg) + TAA | 257 ± 24.38 | 485 ± 19.87 ** | 14 ± 1.48 ** | 3 ± 0.14 ** |
| BCA 25 mg/kg + TAA | 250 ± 4.25 | 430 ± 13.63 ** | 15 ± 1.23 ** | 4 ± 0.52 ** |
| BCA50 mg/kg + TAA | 256 ± 6.72 | 467 ± 8.74 ** | 15 ± 1.72 ** | 4 ± 0.8 ** |
Data expressed as mean ± SEM (n = 6 rats/group). ** p < 0.05 compared with TAA control, * p < 0.05 compared with normal control.